Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentBeginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Picard Medical (PMI) Depreciation & Amortization (CF) (2024 - 2026)

Picard Medical posted quarterly Depreciation & Amortization (CF) of $46000.0 for Q1 2026, up 9.52% year-on-year from $42000.0 in Q1 2025, and up 15.0% on a QoQ basis from $40000.0 in Q4 2025.

Picard Medical (PMI) has 3 years of Depreciation & Amortization (CF) data on file, last reported at $46000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 9.52% year-over-year to $46000.0; the trailing twelve-month figure through Mar 2026 stood at $569136.0 (up 351.7% YoY), and the FY2025 full-year result was $163000.0, down 27.88% from the prior year.
  • Depreciation & Amortization (CF) for Q1 2026 stood at $46000.0, up from $40000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $442136.0 in Q2 2025 and bottomed at $40000.0 in Q4 2025.
  • The 3-year median for Depreciation & Amortization (CF) is $42000.0 (2024), against an average of $99305.1.
  • The widest annual swing landed in 2025, when Depreciation & Amortization (CF) fell 4.76%; it then grew 9.52% in 2026.
  • A 3-year view of Depreciation & Amortization (CF) shows it stood at $42000.0 in 2024, then dropped by 4.76% to $40000.0 in 2025, then increased by 15.0% to $46000.0 in 2026.
  • The last three Depreciation & Amortization (CF) figures came in at $46000.0 (Q1 2026), $40000.0 (Q4 2025), and $41000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 381.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 120.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 749.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 351.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 40.90 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 67.10 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 78.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 123.40 Mn
10 Picard Medical 12.10 Mn 12.10 Mn 275,000.00 46,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 46,000.00
Mar 31, 2026 46,000.00
Dec 31, 2025 40,000.00
Dec 31, 2025 40,000.00
Sep 30, 2025 -563,293.00
Sep 30, 2025 -563,293.00
Jun 30, 2025 442,136.00
Jun 30, 2025 442,136.00
Dec 31, 2024 42,000.00
Dec 31, 2024 42,000.00
Sep 30, 2024 42,000.00
Sep 30, 2024 42,000.00